Search by Drug Name or NDC

    NDC 00025-0333-02 ABRILADA Details

    ABRILADA

    ABRILADA is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is .

    Product Information

    NDC 00025-0333
    Product ID 0025-0333_df88bbe6-cab6-49d0-af20-99bf61a03589
    Associated GPIs
    GCN Sequence Number 080513
    GCN Sequence Number Description adalimumab-afzb SYRINGEKIT 20MG/0.4ML SUBCUT
    HIC3 S2J
    HIC3 Description ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR
    GCN 47379
    HICL Sequence Number 046230
    HICL Sequence Number Description ADALIMUMAB-AFZB
    Brand/Generic Brand
    Proprietary Name ABRILADA
    Proprietary Name Suffix n/a
    Non-Proprietary Name adalimumab-afzb
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Pfizer Laboratories Div Pfizer Inc
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761118
    Listing Certified Through 2024-12-31

    Package

    NDC 00025-0333-02 (00025033302)

    NDC Package Code 0025-0333-02
    Billing NDC 00025033302
    Package 2 KIT in 1 CARTON (0025-0333-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (0025-0329-01) * 1 mL in 1 PACKET (0069-1111-01)
    Marketing Start Date 2023-12-14
    NDC Exclude Flag N
    Pricing Information N/A